Search Results
), ticarcillin/clavulanic acid (75/10 μg), tobramycin (10 μg), netilmicin (30 μg), cefepime (30 μg) cefotaxime (30 μg), ceftazidime (30 μg), ceftriaxone (30 μg), ciprofloxacin (5 μg), levofloxacin (5 μg), ofloxacin (5 μg), meropenem (10 μg), imipenem (10 μg
method according to recommendations of the Clinical and Laboratory Standards Institute (CLSI) [ 21 ]. The antibiotics tested were as follows: cefoxitin (30 μg), levofloxacin (10 μg), gentamicin (10 μg), amikacin (30 μg), cefotaxime (30 μg), tobramycin (10
antimicrobial agents, ampicillin/sulbactam (10/10 µg), meropenem (10 μg), gentamicin (10 μg), doxycycline (30 µg), ciprofloxacin (5 μg), co-trimoxazole (1.25/23.75 μg), cefepime (30 μg), ceftazidime (30 μg), and levofloxacin (30 μg) (Mast, UK). Results were
in this study included ceftazidime, colistin, levofloxacin, polymyxin B, aztreonam, ciprofloxacin, amikacin, cefepime, and piperacillin/tazobactam. In this study, MDR was considered as acquired non-susceptibility to at least one agent in three or more
), gentamicin (GN), tobramycin, levofloxacin (LEV), ciprofloxacin (CIP), nitrofurantoin (F), tetracycline (TE), ertapenem (ETP), imipenem (IPM), and SXT antibiotic disks and the results were evaluated according to the CLSI guidelines [ 12
species, and Stenotrophomonas maltophilia are important causal agents [ 20 ]. In general, HAP should be treated with piperacillin–tazobactam, cefepime, levofloxacin, or a carbapenem. For the treatment of VAP, 3 groups of antibiotics should be considered
, levofloxacin, and moxifloxacin), aminoglycosides (gentamicin and tobramycin), glycopeptides (vancomycin and teicoplanin), the macrolide erythromycin, the lincosamide clindamycin, the streptogramin quinupristin, tetracycline, the glycylcycline tigecycline, the
peak), severe thrombocytopenia (8,000/μl), severe neutropenia (300/μl), anemia [hemoglobin (Hb) 6.6 g/dl], and hepatosplenomegaly. An empirical therapy with different combinations of broad-spectrum antibiotics (levofloxacin, ceftriaxone, meropenem
containing cefixime, cefuroxime axetil, cephalexin·H 2 O, ciprofloxacin HCl, levofloxacin, and metronidazole. In this article, the application of the transfer process is extended by seven products containing eight important drugs of different types
.1155/2016/2475067 4. Wagenlehner FM , Umeh O , Steenbergen J , Yuan G , Darouiche RO . Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary
